Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Steen Kroyer

Director and Partner
AK Consultants
Member of the Healthcare Council

Steen Kroyer is an Independent Consultant in Copenhagen, Denmark. He retired in September 2006 as the President and Chairman of AstraZeneca (AZ) China and Hong Kong. As the President and Chairman for over five years, Mr. Kroyer was responsible for developing the AZ business from sales of 80 million USD in 2001 and 270 million USD in 2005, and expanding the organization from 700 in 2002 to over 2500 until the time of his resignation. His responsibilities ranged from manufacturing operations in Wuxi and Hong Kong to R&D investment strategy and industry and government relations. Mr. Kroyer has spent the past 35 years in the international pharmaceutical industry, including being the President of AZ Norway, President of AZ Poland, President of AZ South Africa, Director of SADC Markets, and many other positions around the world. He has sat on the Executive Committee of RDPAC in China from 2004 to 2006 and was a member of the Advisory Council of EUCC. (This is me - Update Profile)


Employment History
2007 - present Director and Partner
AK Consultants
2002 - 2006 Chairman of the Board
AstraZeneca China & HK
2002 - 2006 President
AstraZeneca China & HK
1999 - 2001 President
AstraZeneca Norway
1999 - 2001 President
AstraZeneca Norway

GLG Study Groups with Steen Kroyer(?)

Steen Kroyer is not a member of any GLG Study Groups.
View All Study Groups

GLG NewsSM Analyses by Steen Kroyer(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Steen Kroyer has not published any public GLG News analyses.
View all GLG News in Healthcare

GLG InstituteSM Seminars with Steen Kroyer(?)

 
Steen Kroyer has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Steen Kroyer









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-02T17:45:17.163